Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
- Yasunori Murata
- , Shigeru Tanzawa
- , Toshihiro Misumi
- , Hiroshige Yoshioka
- , Eisaku Miyauchi
- , Kiichiro Ninomiya
- , Masafumi Takeshita
- , Kensaku Ito
- , Tatsuro Okamoto
- , Shunichi Sugawara
- , Yosuke Kawashima
- , Kazuki Hashimoto
- , Masahide Mori
- , Akihiko Miyanaga
- , Anna Hayashi
- , Hisashi Tanaka
- , Ryoichi Honda
- , Masafumi Nojiri
- , Yuki Sato
- , Akito Hata
- Ichinomiya Nishi Hospital
- National Cancer Center Japan
- Kansai Medical University
- Tohoku University
- Okayama University
- National Hospital Organization Kyushu Cancer Center
- Sendai Kousei Hospital
- National Hospital Organization Osaka Toneyama Medical Center
- Nippon Medical School
- Hirosaki University
- Asahi General Hospital
- Kanazawa Medical University
- Kobe City Medical Center General Hospital
- Kobe Minimally Invasive Cancer Center
- Hiroshima Prefectural Hospital
- National Hospital Organization Shikoku Cancer Center
- Osaka International Cancer Institute
- Chiba University
- Aichi Cancer Center Hospital and Research Institute
- Shizuoka General Hospital
- Suita Municipal Hospital
- Niigata Cancer Center Hospital
- Niigata University
- University of Fukui
- Hiroshima University
- National Hospital Organization Iwakuni Clinical Center
- Aso Iizuka Hospital
- Yokohama Municipal Citizen's Hospital
- Nagano Red Cross Hospital
- Shimane University
- Fukuoka University
- Aichi Medical University
- Japanese Red Cross Nagoya Daiichi Hospital
- Miyagi Cancer Center
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations